clomipramine ( 25-150 mg/day ) was given in a 2-month open clinical trial to patients with dsm-iii defined panic disorder ( n = 8 ) or agoraphobia with panic attacks ( n = 12 ) ;
C0009010
clomipramine
C0030319
panic disorder